2 completed, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
Follow Prescriptions: new trials by email Literature Review of Prescriptions trials Research Report on Prescriptions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer Traditional Chinese Medicine Formulation, Placebo Formulation - Triple Negative Breast Cancer | Phase 3 | Unknown | Fudan University | 200 | 2020-05-25 | 2020-06-01 |
| Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity standard dose prescription, FDG-PET guided gradient dose prescription - Head and Neck Neoplasms, Carcinoma, Squamous Cell | Phase 3 | Completed | Radboud University Medical Center | 300 | 2016-06-01 | 2025-11-18 |
| Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer Rifaximin, Placebo - Rectal Cancer | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 69 | 2011-04-26 | 2024-05-14 |
Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Rectal Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Fudan University (1) · Memorial Sloan Kettering Cancer Center (1) · Radboud University Medical Center (1)
China (1) · Netherlands (1) · United States (1)
Philip Paty, MD (1) · ZhiMin Shao, MD, PhD (1)